Contact David

Login and

Follow Us

About
Podcasts
Archive
Contact

About
Podcasts
Archive
Contact

About
Podcasts
Archive
Contact

Contact

Name*
First Last
Email*
Are you a current subscriber?*
- Yes
- No
How did you find Diabetic Investor?*
How can I help you?*
Name
This field is for validation purposes and should be left unchanged.

David Kliff

If you’re interested in a Corporate or Unlimited licensing, please let me know. Consultation by the hour, day or project is also available.

Subscribe
Podcasts
Archive
FAQs
Press
Contact
Disclaimer
Privacy Policy

Convergence of Forces

Latest Tweets

Novo Nordisk, Gilead, BMS and AstraZeneca will feel the most pain from Biden's pricing bill: analysts https://t.co/5aDVCB7PsO
With Lilly's Mounjaro set for stardom, an Alzheimer's win would be 'icing on the cake': analysts https://t.co/DkdpZtZ82E
Insulet wins CE Mark for Omnipod 5 for children 2 and up https://t.co/OXcHQbvG6T @MassDevice

Recent Posts

Are they ready? September 27, 2022
New design same issue September 22, 2022
Taking on more water September 21, 2022
Just another meatball September 15, 2022
Value Destruction Continues September 13, 2022
Rearranging deck chairs September 12, 2022
Fourth place in 2 horse race September 2, 2022
This obsession has gone too far August 31, 2022
Happy 91 Momma Kliff August 30, 2022
And this means what? August 26, 2022
Tandem or Medtronic August 24, 2022
One last fight? August 23, 2022

© 2005 – 2021 Diabetic Investor, Inc., all rights reserved. Unless expressly permitted under your written license agreement, you are not authorized to forward or to otherwise copy our newsletter, or any portion thereof, by electronic means or otherwise. 17 U.S.C. §504 provides for statutory damages of up to $150,000 per infringement of a copyright and additional damages.